DE602004015096D1 - Neue polymorphe von olanzapin-hydrochlorid - Google Patents

Neue polymorphe von olanzapin-hydrochlorid

Info

Publication number
DE602004015096D1
DE602004015096D1 DE602004015096T DE602004015096T DE602004015096D1 DE 602004015096 D1 DE602004015096 D1 DE 602004015096D1 DE 602004015096 T DE602004015096 T DE 602004015096T DE 602004015096 T DE602004015096 T DE 602004015096T DE 602004015096 D1 DE602004015096 D1 DE 602004015096D1
Authority
DE
Germany
Prior art keywords
new polymorph
new
hydrochloride
olanzapine
olanzapine hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004015096T
Other languages
English (en)
Inventor
Janos Petho
Jozsef Barkoczy
Nagy Peter Kotay
Gyula Simig
Zsuzsa Szent-Kirallyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egis Pharmaceuticals PLC
Original Assignee
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Pharmaceuticals PLC filed Critical Egis Pharmaceuticals PLC
Publication of DE602004015096D1 publication Critical patent/DE602004015096D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602004015096T 2003-04-22 2004-04-22 Neue polymorphe von olanzapin-hydrochlorid Expired - Lifetime DE602004015096D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0301082A HU226410B1 (en) 2003-04-22 2003-04-22 Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them
PCT/HU2004/000042 WO2004094433A1 (en) 2003-04-22 2004-04-22 New polymorphs of olanzapine hydrochloride

Publications (1)

Publication Number Publication Date
DE602004015096D1 true DE602004015096D1 (de) 2008-08-28

Family

ID=89981318

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004015096T Expired - Lifetime DE602004015096D1 (de) 2003-04-22 2004-04-22 Neue polymorphe von olanzapin-hydrochlorid

Country Status (24)

Country Link
US (1) US7951798B2 (de)
EP (1) EP1620439B1 (de)
JP (1) JP4763594B2 (de)
KR (1) KR20060004954A (de)
CN (2) CN100471859C (de)
AT (1) ATE401332T1 (de)
AU (1) AU2004232544B2 (de)
BG (1) BG109361A (de)
CA (1) CA2522734C (de)
CZ (1) CZ2005684A3 (de)
DE (1) DE602004015096D1 (de)
DK (1) DK1620439T3 (de)
EA (1) EA008376B1 (de)
ES (1) ES2310728T3 (de)
HR (1) HRP20080479T3 (de)
HU (1) HU226410B1 (de)
IL (1) IL171522A (de)
PL (2) PL378061A1 (de)
PT (1) PT1620439E (de)
SI (1) SI1620439T1 (de)
SK (1) SK50942005A3 (de)
UA (1) UA80881C2 (de)
WO (1) WO2004094433A1 (de)
ZA (1) ZA200508936B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1575962A1 (de) * 2002-12-24 2005-09-21 Teva Pharmaceutical Industries Limited Neue kristallformen von olanzapin, verfahren zu deren herstellung und verfahren zur herstellung bekannter kristallformen von olanzapin
SI21850A (sl) * 2004-07-28 2006-02-28 Krka, Tovarna Zdravil, D.D., Novo Mesto Soli olanzapina in njihova pretvorba v prosto bazo olanzapina
CA2587710C (en) * 2004-11-16 2014-10-21 Elan Pharma International Ltd. Injectable nanoparticulate olanzapine formulations
HUP0501046A2 (en) 2005-11-11 2007-08-28 Egis Gyogyszergyar Nyilvanosan Process for the preparation of olanzapine
PT2081921E (pt) * 2006-07-10 2010-12-10 Paion Uk Ltd Sais de benzodiazepina de acção curta e suas formas polimórficas
WO2008151430A1 (en) * 2007-06-14 2008-12-18 Apotex Pharmachem Inc. Novel processes to form-i of olanzapine
US20090286294A1 (en) * 2008-04-04 2009-11-19 University Of Massachusetts Methods and Compositions for Improving the Production of Fuels in Microorganisms
EP2450039A1 (de) 2010-11-08 2012-05-09 PAION UK Ltd. Dosierschema zur Sedierung mit CNS 7056 (Remimazolam)
PT2729474T (pt) * 2011-07-08 2018-06-05 Lilly Co Eli Compostos (tieno[2,3-b][1,5]benzoxazepin-4-il)piperazin-1-ilo tendo actividade dual como agonistas inversos de h1/antagonistas de 5-ht2a
EA026328B1 (ru) * 2013-01-14 2017-03-31 Эли Лилли Энд Компани (ТИЕНО[2,3-b][1,5]БЕНЗОКСАЗЕПИН-4-ИЛ)ПИПЕРАЗИН-1-ИЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ АГЕНТОВ С ДВОЙНОЙ АКТИВНОСТЬЮ: ОБРАТНЫХ АГОНИСТОВ Н1/АНТАГОНИСТОВ 5-НТ
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión
KR101489062B1 (ko) * 2013-03-28 2015-02-02 동아에스티 주식회사 고순도의 올란자핀 및 이의 결정형 ii의 제조방법
JP6940866B2 (ja) * 2017-06-21 2021-09-29 国立研究開発法人情報通信研究機構 半導体光デバイス、半導体光源、光集積回路、及び半導体光デバイスの製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
IL135295A0 (en) * 1997-09-30 2001-05-20 Lilly Co Eli 2-methyl-thieno-benzodiazepine formulation
DK1119359T3 (da) * 1998-09-30 2004-08-16 Lilly Co Eli 2-methyl-thieno-benzodiazepinformulering
UA80095C2 (en) 2001-07-20 2007-08-27 Lilly Co Eli 2 methyl-thieno-benzodiazepine lyophilized formulation and method for the preparation thereof
AR047459A1 (es) * 2004-01-27 2006-01-18 Synthon Bv Sales estables de 2-metil-4-(4-metil-1-piperazinil)-10h-tieno[2,3-b][1,5]benzodiazepina (olanzapina)

Also Published As

Publication number Publication date
IL171522A (en) 2010-05-31
PT1620439E (pt) 2008-10-23
EA200501633A1 (ru) 2006-04-28
ZA200508936B (en) 2008-07-30
JP2006524219A (ja) 2006-10-26
US20070004706A1 (en) 2007-01-04
CZ2005684A3 (cs) 2006-01-11
CN100471859C (zh) 2009-03-25
UA80881C2 (en) 2007-11-12
DK1620439T3 (da) 2008-11-17
HUP0301082A2 (hu) 2004-12-28
PL1620439T3 (pl) 2009-02-27
KR20060004954A (ko) 2006-01-16
AU2004232544B2 (en) 2010-06-03
CN1777613A (zh) 2006-05-24
CN101468999B (zh) 2012-05-09
WO2004094433A1 (en) 2004-11-04
CN101468999A (zh) 2009-07-01
ES2310728T3 (es) 2009-01-16
EP1620439A1 (de) 2006-02-01
EA008376B1 (ru) 2007-04-27
EP1620439B1 (de) 2008-07-16
BG109361A (bg) 2006-09-29
SI1620439T1 (sl) 2009-06-30
ATE401332T1 (de) 2008-08-15
CA2522734C (en) 2010-05-25
JP4763594B2 (ja) 2011-08-31
AU2004232544A1 (en) 2004-11-04
PL378061A1 (pl) 2006-02-20
CA2522734A1 (en) 2004-11-04
HU226410B1 (en) 2008-11-28
HU0301082D0 (en) 2003-06-28
HRP20080479T3 (en) 2008-10-31
US7951798B2 (en) 2011-05-31
SK50942005A3 (sk) 2006-02-02

Similar Documents

Publication Publication Date Title
AR002719A1 (es) Forma ii polimorfa 2-metil-4-(4-metil-1-piperacinil)-10h-tieno[2,3-b]-[1,5] benzodiacepina(olanzapina) y formulaciones farmaceuticas que las contienen.
DE602004015096D1 (de) Neue polymorphe von olanzapin-hydrochlorid
MA27080A1 (fr) Forme polymorphe du rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
BG108868A (en) Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds
DE60230327D1 (de) Polymorphe von clopidogrel-hydrogensulfat
ATE365742T1 (de) 4-aminothieno(2,3-d) pyrimidin -6-carbonitril- derivative zur verwendung als pde7 inhibitoren
EA200601418A1 (ru) ПРОИЗВОДНЫЕ 1Н-ТИЕНО [2,3-с] ПИРАЗОЛА, ПРЕДНАЗНАЧЕННЫЕ ДЛЯ ИСПОЛЬЗОВАНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ КИНАЗЫ
DE60336226D1 (de) Verfahren zur herstellung von olanzapin form i
PL1682528T3 (pl) Pochodne benzo[b][1,4]dioksepiny
PT1165544E (pt) 1,4-di-hidroindeno¬1,2-c|pirazoles substituidos como inibidores de tirosina-quinase
EA200601921A1 (ru) Полиморфные формы гидробромида метил-(+)-(s)-альфа-(2-хлорфенил)-6,7-дигидротиено [3,2-c] пиридин-5(4н)-ацетата, гидробромида клопидогреля
IS6437A (is) Ný setin pýrazóló [4,3-e]díazepín lyfjasamsetningar sem innihalda þau, notkun sem læknandi afurðir og aðferðir við framleiðslu þeirra
WO2003037903A8 (en) Olanzapine dihydrate-ii a process for its preparation and use thereof
SG113595A1 (en) New benzo[b]chromeno-naphthyridin-7-one and pyrano[2',3':7,8] quino[2,3-b]quinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them
EA201001278A1 (ru) Способ получения оланзапина
SE0100295D0 (sv) New compounds
SE0100296D0 (sv) New compounds
SE0303451D0 (sv) New compounds
DK1392698T3 (da) Fremgangsmåde til fremstilling af 6-aryl-4H-s-triazolo-[3,4-c]thieno[2,3-e]-1,4-diazepiner
TH78308B (th) อนุพันธ์ของเฮทเทอโรไซคลิคไพราโซลที่ทำปฏิกิริยารวมตัวแล้วในฐานะที่เป็นสารยับยั้งไคเนส
ECSP961694A (es) Procedimeinto para preparar olanzapina (caso x - 9992m)
UA86772C2 (en) Process for the preparation of the polymorph form of methyl (s)-(+)-(2-chlorophenyl)-2-(6,7-dihydro-4h-thieno[3,2-c]pyridine-5-yl-acetate hydrogensulfate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition